Regulatory myeloid immune cells, such as myeloid-derived suppressor cells (MDSCs), populate inflamed or cancer tissue and block immune cell effector functions. Lack of mechanistic insight 54 into MDSC suppressive activity and a marker for their identification hampered attempts to 55 overcome T cell-inhibition and unleash anti-cancer immunity. Here we report that human MDSCs 56 were characterized by strongly reduced metabolism and conferred this compromised metabolic 57 state to CD8 + T cells thereby paralyzing their effector functions. We identified accumulation of the dicarbonyl-radical methylglyoxal, generated by semicarbazide-sensitive amine oxidase (SSAO), to cause the metabolic phenotype of MDSCs and MDSC-mediated paralysis of CD8 + T cells. In a murine cancer model, neutralization of dicarbonyl-activity overcame MDSC-mediated T cell-suppression and together with checkpoint inhibition improved efficacy of cancer immune therapy. Our results identify the dicarbonyl methylglyoxal as marker metabolite for MDSCs that mediates T cell paralysis and can serve as target to improve cancer immune therapy. Results 92 Dormant metabolic phenotype in MDSCs 93Suppressive myeloid cells arise during chronic inflammation in tissues 17 , and tissue stromal cells 94 induce transition of monocytes into monocytic MDSCs 16 . We exploited this capacity of stromal cells to convert human peripheral blood monocytes into MDSCs, which are phenotypically similar 96 to CD14 + HLA-DR -/low suppressive myeloid cells directly isolated from cancer patients 16 , to characterize the mechanism of MDSC-mediated T cell suppression. Transcriptome analysis showed less than 200 differentially expressed genes between MDSCs and monocytes, which did not include surface molecules suitable for phenotypic discrimination or known immune suppressive mediators to explain their suppressive activity (supplementary table I-IV, Extended Data Fig. 1). Consistently, blockade of known immune suppressive mediators did not prevent MDSC-mediated T cell suppression (Extended Data Fig. 2). Surprisingly, we found downregulation of genes encoding glycolysis-related enzymes in MDSCs (Fig. 1a, and Extended Data Table V).Indeed, MDSCs showed reduced glucose uptake and Glut1 surface expression (Fig. 1b), the main transporter mediating glucose uptake in immune cells. As predicted from gene expression analysis, hexokinase activity was lower in MDSCs (Fig. 1c). To validate these results, we isolated CD14 + HLA-DR -/lo cells from tumor tissue of patients with hepatocellular carcinoma by enzymatic digestion followed by density centrifugation and flow cytometric cell sorting. We confirmed reduced glucose uptake and hexokinase activity in CD14 + HLA-DR -/low cells isolated from tumor tissue of cancer patients (Fig. 1d,e, and Extended Data Table VI), which are considered to represent MDSCs. Strikingly, MDSCs failed to utilize glucose for glycolysis and also showed reduced cellular bioenergetics, i.e. lower mitochondrial membrane potential quantified by the potentiometric mitochondrial ...

Nonalcoholic fatty liver disease (NAFLD) is a major health burden in the aging society with an urging medical need for a better understanding of the underlying mechanisms. Mitochondrial fatty acid oxidation and mitochondrial‐derived reactive oxygen species (ROS) are considered critical in the development of hepatic steatosis, the hallmark of NAFLD. Our study addressed in C57BL/6J mice the effect of high fat diet feeding and age on liver mitochondria at an early stage of NAFLD development. We therefore analyzed functional characteristics of hepatic mitochondria and associated alterations in the mitochondrial proteome in response to high fat feeding in adolescent, young adult, and middle‐aged mice. Susceptibility to diet‐induced obesity increased with age. Young adult and middle‐aged mice developed fatty liver, but not adolescent mice. Fat accumulation was negatively correlated with an age‐related reduction in mitochondrial mass and aggravated by a reduced capacity of fatty acid oxidation in high fat‐fed mice. Irrespective of age, high fat diet increased ROS production in hepatic mitochondria associated with a balanced nuclear factor erythroid‐derived 2 like 2 (NFE2L2) dependent antioxidative response, most likely triggered by reduced tethering of NFE2L2 to mitochondrial phosphoglycerate mutase 5. Age indirectly influenced mitochondrial function by reducing mitochondrial mass, thus exacerbating diet‐induced fat accumulation. Therefore, consideration of age in metabolic studies must be emphasized.

No abstract